Could Alzheimer's be predicted with a finger-prick test? An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.

#Alzheimers #Alzheimersdiagnostics #Alzheimersdisease #cognitivedecline #BioHermes002study #bloodbasedbiomarkertesting #bloodbasedbiomarkers #biomarkers #pTau217 #GFAP #NfL #LifeArc #GAP #UKDRI #vasculardementia #frontotemporaldementia #dementiawithLewybodies #AlzheimersAssociation
zurl.co/64c0o

Revolutionizing Alzheimer's Diagnosis with a Simple Finger Prick Blood Test A groundbreaking study is underway to see if a finger prick blood test can effectively diagnose Alzheimer's early, changing the landscape of treatment options.

Revolutionizing Alzheimer's Diagnosis with a Simple Finger Prick Blood Test #London #United_Kingdom #Alzheimer's_Disease #LifeArc #Bio-Hermes-002

Some amazing work that's all over the News this morning. This important work is co-funded by @lifearc.bsky.social who also co-fund our LifeArc Centre for Rare Mitochondrial Diseases bit.ly/4moq7xV

#rarediseases #LifeArc

Great day at the LifeArc Translational Centres Annual Showcase!👩‍🔬

Liz and Clare attended the event yesterday, hearing inspiring updates from all four Centres and connecting with professionals working in rare disease across the UK. 🧬

#TheLilyFoundation #LifeArc

A group of us from the LifeArc Centre for Rare Mitochondrial Diseases bit.ly/4moq7xV attended the LifeArc Translational Centres for Rare Diseases Annual Showcase yesterday @lifearc.bsky.social. Great to make connections and share knowledge with the other rare disease centres
#LifeArc #rarediseases

Charities call for shake-up in UK rare disease R&D LifeArc and Genetics Alliance UK have issued a call to the government to remove obstacles impeding R&D into rare diseases.

Medical research charities #LifeArc and #GeneticsAllianceUK have issued a call to the government to topple obstacles impeding R&D into #rarediseases that are "costing lives and money."

Photo of Delegates at the meeting convene for refreshment under a shady tent.

Photo of WACCBIP sign at the University of Ghana

The @crickafricanetwork.bsky.social is meeting this week in Accra… hosted by #WACCBIP 🧪🇬🇭
A very warm welcome (in every sense!).

Day 1: Pathogen biology, vaccines, microscopy, diagnostics, careers, funding, connections, sustainable democratisation of skills & technology.
@crick.ac.uk #LifeArc

UCL researchers launch congenital muscular dystrophy research programme - PharmaTimes The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK

#congenitalmusculardystrophy #CMD #LifeArc #MuscularDystrophyUK #UCL #congenitalmusculardystrophyresearchprogramme #LMNArelatedCMD #collagenVIrelatedCMD #neuromusculardisorders #musclefibroblasttargeting #patients #merosindeficientCMD
pharmatimes.com/news/ucl-res...

It was great to hear from our CEO at #AACR2025 about how we can develop more effective, targeted therapeutics for children and young people with cancer, bringing more cures to clinic.

Learn more about #CFurther, our consortium with #LifeArc for #CYP cancers: www.c-further.org

Podcast promo for Cancer Research Horizons: “Partnerships to beat cancer.” Episode 6 features Curtis Asante and Matt Ashenden discussing how C-Further is driving innovation for childhood cancer. Includes a “Listen now” button and microphone icon.

Tackling childhood cancer takes strong partnerships 💪

In the latest “Partnerships to beat cancer” episode, we explore how #CFurther, our consortium for children and young people's cancers with #LifeArc, is driving innovation in this space.

🎧 Tune in: bit.ly/4lsJC9i

QR code for 3 jobs

📢 We have not 1 but 3 clinical/patient-facing jobs working with #mitoCAMB on the #LifeArc #raredisease centre for #mito diseases.

1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator

Join us! Links below.

Brain drug cure needed for future 'trapped in' generations Scientists hope to find a cure for a genetic condition linked back to a single Cumbrian family line.

BBC news article about one of our patients with #neuroferritinopathy on the DefINe clinical trial, funded by #LifeArc. Spread the word about this disease, and also this trial - more participants needed!

www.bbc.com/news/article...

@ritahorvath.bsky.social @jellevda.bsky.social

Description Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...

Looking for a #Research #Project #Manager with interest in #CF and #infection to work in a multidisciplinary team based out of @imperialnhli.bsky.social @imperialmed.bsky.social funding from @cftrustuk.bsky.social and #LifeArc
www.imperial.ac.uk/jobs/search-...

LifeArc on LinkedIn: Rare disease research faces unique challenges including lack of… Rare disease research faces unique challenges including lack of investment, small patient populations, fragmented research and challenging routes to…

Very excited to share this #LifeArc video about the 4 new #rare disease centres across the UK, with our centre for #mitochondrial diseases being one of them!

@jellevda.bsky.social @ritahorvath.bsky.social @frisophagy.bsky.social @mrc-mbu.bsky.social

www.linkedin.com/posts/lifear...

Our #research #ChristmasCountdown continues!

SCTU is part of a multi-million-pound "Innovation Hub", led by @officialuom.bsky.social, which aims to improve treatments for people with the lung condition #CysticFibrosis.

Read more - bit.ly/3Y8FNMK

@cftrustuk.bsky.social #LifeArc #AdventCalendar

Centauri Therapeutics awarded grant to advance immunotherapy platform in anti-infectives - Pf Media Immunotherapy company, Centauri Therapeutics, has been awarded a £1M grant by Pathways to Antimicrobial Clinical Efficacy (PACE).

#medtech #antiinfectives #immunotherapy #CentauriTherapeutics #PathwaystoAntimicrobialClinicalEfficacy #PACE #Alphamer #Alphamertechnology #MultiDrugResistant #MDR #InnovateUK #LifeArc #MedicinesDiscoveryCatapult #antimicrobialresistance #antimicrobialinnovations
pf-media.co.uk/news/centaur...